A Phase 1 Study of 4 Live, Recombinant Human Cytomegalovirus Towne/Toledo Chimera Vaccines in Cytomegalovirus-Seronegative Men.

Saved in:
Bibliographic Details
Title: A Phase 1 Study of 4 Live, Recombinant Human Cytomegalovirus Towne/Toledo Chimera Vaccines in Cytomegalovirus-Seronegative Men.
Authors: Adler SP; CMV Research Foundation., Manganello AM; CMV Research Foundation., Lee R; Department of Pediatrics., McVoy MA; Department of Pediatrics., Nixon DE; Department of Internal Medicine, Virginia Commonwealth University, Richmond., Plotkin S; University of Pennsylvania.; Wistar Institute, Philadelphia, Pennsylvania., Mocarski E; Department of Microbiology and Immunology, Emory Vaccine Center, Emory University, Atlanta, Georgia., Cox JH; International AIDS Vaccine Initiative, New York., Fast PE; International AIDS Vaccine Initiative, New York., Nesterenko PA; Department of Molecular Microbiology and Immunology, Oregon Health and Science University., Murray SE; Department of Molecular Microbiology and Immunology, Oregon Health and Science University.; Department of Biology, University of Portland, Oregon., Hill AB; Department of Molecular Microbiology and Immunology, Oregon Health and Science University., Kemble G; 3-V Biosciences, Menlo Park, California.
Source: The Journal of infectious diseases [J Infect Dis] 2016 Nov 01; Vol. 214 (9), pp. 1341-1348. Date of Electronic Publication: 2016 Aug 11.
Publication Type: Clinical Trial, Phase I; Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first